Liothyronine sodium
NDC 70771-1608, Liothyronine sodium, tablet, from Zydus Lifesciences Limited.
- Product NDC
- 70771-1608
- Status
- Listed
- Labeler
- Zydus Lifesciences Limited
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214803
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1608 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LIOTHYRONINE SODIUM50 ug/1
Pharmacologic classes
Triiodothyronine [CS]; l-Triiodothyronine [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70771-1608-0 | 70771160800 | 1000 TABLET in 1 BOTTLE (70771-1608-0) |
| 70771-1608-1 | 70771160801 | 100 TABLET in 1 BOTTLE (70771-1608-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/4fb09346-3d30-4a7c-a97c-480d5924997a
Use it
Look up 70771-1608 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1608 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70771-1608. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.